Patents by Inventor Sandra Quackenbush

Sandra Quackenbush has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Apoptotic upregulation by myxoma virus expressing walleye dermal sarcoma virus orfC
    Patent number: 11591616
    Abstract: A recombinant myxoma virus that encodes the orfC gene of walleye dermal sarcoma virus (WDSV). The orfC gene of walleye dermal sarcoma virus (WDSV) plays a role in induction of seasonal regression of tumors caused by WDSV. This gene was isolated from WDSV and recombined into myxoma virus (MYXV orfC) for use as an oncolytic therapy. The recombinant myxoma virus can be used in oncolytic virus therapy to specifically target and lyse cancer cells without harming healthy cells in cancer patients.
    Type: Grant
    Filed: April 22, 2020
    Date of Patent: February 28, 2023
    Assignee: Colorado State University Research Foundation
    Inventors: Amy MacNeill, Sandra Quackenbush, Laura Ashton